Clinical Trial Update: Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Qidong Yixin Granule to prevent atrial fibrillation recurrence after ablation. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Qidong Yixin Granule

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Persistent Atrial Fibrillation | Phase 4 | Status: RECRUITING